Anna Piekarska
Mazowiecka Str. 6/8
Lodz, LD 92215, Poland
Lodz, LD 92215, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Prevalence and predictors of HCV infection among hospitalized psychiatric patients in Poland.
Journal: Frontiers in psychiatry
Published: March 20, 2026
Clinical characteristics of hospitalized patients with hepatitis E virus infection in Poland: a multi-centre retrospective study.
Journal: Advances in medical sciences
Published: October 16, 2025
Recommendations for hypolipidemic and antithrombotic therapy in HCV-infected patients treated with direct-acting antiviral agents: expert position statement.
Journal: Clinical and experimental hepatology
Published: August 01, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: July 23, 2025
Unraveling Poland's unprecedented influenza surge in early 2025: increased viral severity or post-pandemic vulnerability?
Journal: Pharmacological reports : PR
Published: March 23, 2025
Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025.
Journal: Journal of clinical medicine
Published: March 04, 2025
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.
Journal: World journal of hepatology
Published: February 10, 2025
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Journal: Scientific reports
Published: December 23, 2024
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.
Journal: Journal of clinical medicine
Published: October 27, 2024
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination.
Journal: BMC medicine
Published: September 03, 2024
Last Updated: 09/26/2026